Can we predict who will do well after hip surgery?
NCT ID NCT04243447
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 747 young, active people (ages 14-40) who had hip surgery for femoroacetabular impingement (FAI). Researchers want to find out which patient traits, disease features, and surgical factors lead to the best outcomes. Participants fill out surveys about pain, function, and quality of life over time. The goal is to help doctors and patients make better decisions about surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict which patients will benefit most from hip surgery for FAI.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test a new therapy, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
747 people
The number who actually took part.
- Started
-
Feb 2020
- Expected to finish
-
Nov 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Skeletally mature patients being treated surgically for FAI after failing conservative treatment.
- Ages
-
14 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age 14 - 40 years 2. Skeletally Mature 3. Failure of 6 weeks of conservative treatment 4. Primary surgery (Hip Arthroscopic Treatment) a. Surgical treatment of FAI with hip arthroscopy 5. Tonnis 0 -1 OA, with greater than 2 mm of joint space 6. Clinical diagnosis of FAI (cam or combined; alpha \>50 degrees) Exclusion Criteria: 1. Not a surgical candidate 2. Skeletally Immature 3. Acetabular Dysplasia (LCEA \< 20) 4. Tonnis 2+ OA 5. Previous ipsilateral hip surgery 6. Previous major hip trauma (hip fractures, hip dislocations) 7. Additional disease processes (e.g., Avascular Necrosis (AVN), synovial disease, Ehlers-Danlos Syndrome (EDS), neuromuscular disorders) 8. Unable to consent due to mental faculty 9. Pregnant women 10. Non-English speaking patients 11. Prisoners or other vulnerable populations
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Femoracetabular impingement are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
CHU de Quebec - Universite Laval
Québec, Quebec, Canada
-
Children's Hospital of Eastern Ontario
Ottawa, Ontario, (+4) K1H 8L1, Canada
-
Mayo Clinic
Rochester, Minnesota, 55902, United States
-
San Antonio Military Medical Center
San Antonio, Texas, 78219, United States
-
Scottish Rite Hospital for Children
Dallas, Texas, 75219, United States
-
The Ottawa Hospital
Ottawa, Ontario, Canada
-
Twin Cities Orthopedics
Edina, Minnesota, 55435, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Michigan
Ann Arbor, Michigan, 48106, United States
-
University of Wisconsin, Madison
Madison, Wisconsin, 53706, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.